Closed Loop and Education for Hypoglycemia Awareness Restoration - Trial NCT06325202
Access comprehensive clinical trial information for NCT06325202 through Pure Global AI's free database. This phase not specified trial is sponsored by Milton S. Hershey Medical Center and is currently Not yet recruiting. The study focuses on Diabetes Mellitus, Type 1. Target enrollment is 324 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Milton S. Hershey Medical Center
Timeline & Enrollment
N/A
Jul 01, 2024
Dec 31, 2027
Primary Outcome
epinephrine (pg/ml),Towler questionnaire
Summary
The purpose of the CLEAR study is to determine the effect on counterregulatory responses
 (CRR) of intervening (by attempting to strictly avoid hypoglycemia) to improve awareness of
 hypoglycemic symptoms among adults with type 1 diabetes (T1D) who have impaired awareness of
 hypoglycemia (IAH). IAH affects 20-25% of adults with T1D, and rises with increasing duration
 of T1D.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06325202
Device Trial